| CTRI Number |
CTRI/2025/05/087912 [Registered on: 30/05/2025] Trial Registered Prospectively |
| Last Modified On: |
29/01/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Case Control Study |
| Study Design |
Other |
|
Public Title of Study
|
a study to identify the risk factors of PCOS |
Scientific Title of Study
Modification(s)
|
A case-control study to assess the prevalence and risk factors of metabolic syndrome among females with and without PCOS in A tertiary care hospital, New Delhi |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Satarupa Sarkar |
| Designation |
M.Sc. Nursing Student |
| Affiliation |
College Of Nursing, AIIMS Delhi |
| Address |
Pota cabin 2, 2nd floor, College of Nursing, AIIMS New Delhi 110049
South DELHI 110049 India |
| Phone |
09679281700 |
| Fax |
|
| Email |
satarupa.sarkar2424@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr. Shashi Mawar |
| Designation |
Associate professor |
| Affiliation |
College Of Nursing, AIIMS Delhi |
| Address |
room no 4, Pota cabin 2, 2nd floor, College of Nursing, AIIMS New Delhi 110049
South DELHI 110049 India |
| Phone |
8800228317 |
| Fax |
|
| Email |
drshashimawar@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Satarupa Sarkar |
| Designation |
M.Sc. Nursing Student |
| Affiliation |
College Of Nursing, AIIMS Delhi |
| Address |
Pota cabin 2, 2nd floor, College of Nursing, AIIMS New Delhi 110029
South DELHI 110049 India |
| Phone |
09679281700 |
| Fax |
|
| Email |
satarupa.sarkar2424@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
AIIMS NEW DELHI |
| Address |
Pota cabin 2, 2nd floor, College of Nursing AIIMS Delhi 110029 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Shashi Mawar |
All India Institute of Medical Sciences New Delhi |
mother and child block, ground floor, Obstetrics and gynecology OPD South DELHI |
8800228317
drshashimawar@gmail.com |
|
Details of Ethics Committee
Modification(s)
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| INSTITUTE ETHICS COMMITTEE FOR POST GRADUATE RESEARCH, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI 110029 |
Approved |
| INSTITUTE ETHICS COMMITTEE FOR POST GRADUATE RESEARCH, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI 110029 |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: E282||Polycystic ovarian syndrome, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
nil |
nil |
| Comparator Agent |
nil |
nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Female |
| Details |
1 Females aged 18–40years.
2 Women who had a clinical diagnosis of PCOS based on medical evaluation.
3 Women who give consent to participate in the study.
|
|
| ExclusionCriteria |
| Details |
1 Pregnancy or lactation.
2 Use of medications which has an effect in metabolic parameters
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| to identify risk factors |
1 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| nil |
nil |
|
Target Sample Size
Modification(s)
|
Total Sample Size="142" Sample Size from India="250"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Open to Recruitment |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form
- Who will be able to view these files?
Response - Researchers who provide a methodologically sound proposal.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [satarupa.sarkar2424@gmail.com].
- For how long will this data be available start date provided 30-11-2026 and end date provided 19-07-2031?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
A case control study will be conducted to assess the prevalence of metabolic syndrome among females with PCOS in tertiary care hospital in India. This study aims to assess the prevalence of metabolic syndrome in women with PCOS and explore the metabolic risk factors compared to non-PCOS controls. Population of the study will be females diagnosed with PCOS for case group and general population not diagnosed with PCOS for control group. The data collection process for a PCOS study. It involves recruiting women with PCOS and age-matched controls, obtaining informed consent, and collecting detailed information. This includes demographic data, reproductive history, lifestyle factors, and family history. Physical measurements like weight, height, and waist circumference are taken, along with blood pressure and blood samples for biochemical analysis. Finally, participants are assessed for metabolic syndrome based on established criteria. |